Published in N Engl J Med on April 04, 2011
Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med (2011) 6.65
Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation (2012) 3.61
Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy. N Engl J Med (2016) 3.40
Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol (2013) 3.15
Myocardial viability and impact of surgical ventricular reconstruction on outcomes of patients with severe left ventricular dysfunction undergoing coronary artery bypass surgery: results of the Surgical Treatment for Ischemic Heart Failure trial. J Thorac Cardiovasc Surg (2014) 2.62
Injectable shear-thinning hydrogels used to deliver endothelial progenitor cells, enhance cell engraftment, and improve ischemic myocardium. J Thorac Cardiovasc Surg (2015) 2.43
Severity of Remodeling, Myocardial Viability, and Survival in Ischemic LV Dysfunction After Surgical Revascularization. JACC Cardiovasc Imaging (2015) 2.10
Lifetime analysis of hospitalizations and survival of patients newly admitted with heart failure. Circ Heart Fail (2012) 1.92
Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial. Circulation (2012) 1.91
Extent of coronary and myocardial disease and benefit from surgical revascularization in ischemic LV dysfunction [Corrected]. J Am Coll Cardiol (2014) 1.74
Importance of Angina in Patients With Coronary Disease, Heart Failure, and Left Ventricular Systolic Dysfunction: Insights From STICH. J Am Coll Cardiol (2015) 1.55
Long-term survival of patients with ischemic cardiomyopathy treated by coronary artery bypass grafting versus medical therapy. Ann Thorac Surg (2012) 1.54
Exercise capacity and mortality in patients with ischemic left ventricular dysfunction randomized to coronary artery bypass graft surgery or medical therapy: an analysis from the STICH trial (Surgical Treatment for Ischemic Heart Failure). JACC Heart Fail (2014) 1.41
[Not Available]. Kardiol Pol (2011) 1.39
Edifoligide and long-term outcomes after coronary artery bypass grafting: PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) 5-year results. Am Heart J (2012) 1.22
Core lab analysis of baseline echocardiographic studies in the STICH trial and recommendation for use of echocardiography in future clinical trials. J Am Soc Echocardiogr (2012) 1.13
Trends in acute kidney injury, associated use of dialysis, and mortality after cardiac surgery, 1999 to 2008. Ann Thorac Surg (2012) 1.10
Future directions for cardiovascular disease comparative effectiveness research: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol (2012) 1.09
Influence of crossover on mortality in a randomized study of revascularization in patients with systolic heart failure and coronary artery disease. Circ Heart Fail (2013) 1.04
Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Circulation (2012) 1.04
Impact of cardiovascular magnetic resonance on management and clinical decision-making in heart failure patients. J Cardiovasc Magn Reson (2013) 0.98
Underestimating medical therapy for coronary disease... again. N Engl J Med (2011) 0.95
Heart failure in sub-Saharan Africa. Curr Cardiol Rev (2013) 0.94
Treatment options in end-stage heart failure: where to go from here? Neth Heart J (2012) 0.92
Epicardial placement of mesenchymal stromal cell-sheets for the treatment of ischemic cardiomyopathy; in vivo proof-of-concept study. Mol Ther (2014) 0.91
Does imaging-guided selection of patients with ischemic heart failure for high risk revascularization improve identification of those with the highest clinical benefit?: Myocardial imaging should not exclude patients with ischemic heart failure from coronary revascularization. Circ Cardiovasc Imaging (2012) 0.90
The role of cardiac magnetic resonance imaging following acute myocardial infarction. Eur Radiol (2012) 0.89
Prognostic significance of biomarkers in predicting outcome in patients with coronary artery disease and left ventricular dysfunction: results of the biomarker substudy of the Surgical Treatment for Ischemic Heart Failure trials. Circ Heart Fail (2013) 0.87
Fractional flow reserve-guided percutaneous coronary intervention is not a valid concept. Circulation (2014) 0.86
Tissue-engineered, hydrogel-based endothelial progenitor cell therapy robustly revascularizes ischemic myocardium and preserves ventricular function. J Thorac Cardiovasc Surg (2014) 0.85
Hotline update of clinical trials and registries presented at the American College of Cardiology Congress 2011. Clin Res Cardiol (2011) 0.85
Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF). Eur J Heart Fail (2013) 0.84
Mechanisms of functional mitral regurgitation in ischemic cardiomyopathy determined by transesophageal echocardiography (from the Surgical Treatment for Ischemic Heart Failure Trial). Am J Cardiol (2013) 0.83
Optimal revascularization for complex coronary artery disease. Nat Rev Cardiol (2013) 0.83
Molecular and cellular basis of viable dysfunctional myocardium. Circ Heart Fail (2014) 0.83
Predictors of immediate and long-term outcomes of coronary bypass surgery in patients with left ventricular dysfunction. Heart Vessels (2015) 0.83
Surgical approaches to left ventricular reconstruction: a matter of perspective. Heart Fail Rev (2013) 0.82
Normalization of postinfarct biomechanics using a novel tissue-engineered angiogenic construct. Circulation (2013) 0.82
Chronic total occlusion: To treat or not to treat. World J Cardiol (2014) 0.82
Hotline update of clinical trials and registries presented at the at the European Society of Cardiology Congress in Paris 2011. Clin Res Cardiol (2011) 0.81
Assessment of myocardial ischemia with cardiovascular magnetic resonance. Prog Cardiovasc Dis (2011) 0.81
The prognostic role of stress echocardiography in a contemporary population and the clinical significance of limited apical ischaemia. Echo Res Pract (2016) 0.80
A meta-analysis of the therapeutic effects of glucagon-like Peptide-1 agonist in heart failure. Int J Pept (2012) 0.80
Burden and Prevention of Adverse Cardiac Events in Patients with Concomitant Chronic Heart Failure and Coronary Artery Disease: A Literature Review. Cardiovasc Ther (2016) 0.80
Prevalence of scarred and dysfunctional myocardium in patients with heart failure of ischaemic origin: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson (2011) 0.80
Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) IMAGE HF Project I-A: study protocol for a randomized controlled trial. Trials (2013) 0.80
The amount of dysfunctional but viable myocardium predicts long-term survival in patients with ischemic cardiomyopathy and left ventricular dysfunction. Int J Cardiovasc Imaging (2013) 0.79
Cardiac surgery 2015 reviewed. Clin Res Cardiol (2016) 0.79
Intended versus inferred care after PET performed for initial staging in the National Oncologic PET Registry. J Nucl Med (2013) 0.79
Diabetes is a predictor of coronary artery stenosis in patients hospitalized with heart failure. Heart Vessels (2015) 0.79
Myocardial viability as integral part of the diagnostic and therapeutic approach to ischemic heart failure. J Nucl Cardiol (2015) 0.78
NHLBI integrated pediatric guidelines: battle for a future free of cardiovascular disease. Future Cardiol (2013) 0.78
Temporary epicardial cardiac resynchronisation versus conventional right ventricular pacing after cardiac surgery: study protocol for a randomised control trial. Trials (2012) 0.78
Pediatric lipid management: an earlier approach. Endocrinol Metab Clin North Am (2014) 0.78
The STICH trial (Surgical Treatment for Ischemic Heart Failure): mode-of-death results. JACC Heart Fail (2013) 0.78
Site selection for heart failure clinical trials in the USA. Heart Fail Rev (2015) 0.78
Cardiac MR for the assessment of myocardial viability. Methodist Debakey Cardiovasc J (2013) 0.77
Preoperative intra-aortic balloon pump improves the clinical outcomes of off-pump coronary artery bypass grafting in left ventricular dysfunction patients. Sci Rep (2016) 0.77
Impaired coronary flow reserve is the most important marker of viable myocardium in the myocardial segment-based analysis of dual-isotope gated myocardial perfusion single-photon emission computed tomography. Korean J Radiol (2014) 0.77
CABG in patients with left ventricular dysfunction. N Engl J Med (2011) 0.77
Stable angina pectoris: antianginal therapies and future directions. Nat Rev Cardiol (2011) 0.77
Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST trial. Eur J Heart Fail (2012) 0.77
The role of myocardial viability in contemporary cardiac practice. Heart Fail Rev (2017) 0.77
Review of Journal of Cardiovascular Magnetic Resonance 2011. J Cardiovasc Magn Reson (2012) 0.76
Assessing quality-of-life outcomes in cardiovascular clinical research. Nat Rev Cardiol (2016) 0.75
New Insights in the Diagnosis and Treatment of Heart Failure. Biomed Res Int (2015) 0.75
Quality-of-life outcomes with coronary artery bypass graft surgery in ischemic left ventricular dysfunction: a randomized trial. Ann Intern Med (2014) 0.75
Relation of Angina Pectoris to Outcomes, Quality of Life, and Response to Exercise Training in Patients With Chronic Heart Failure (from HF-ACTION). Am J Cardiol (2016) 0.75
Mitral valve repair for ischemic mitral regurgitation: lessons from the Cardiothoracic Surgical Trials Network randomized study. J Thorac Dis (2016) 0.75
ACP Journal Club. CABG added no benefit to medical therapy for preventing death in CAD with heart failure. Ann Intern Med (2011) 0.75
Almanac 2011: stable coronary artery disease. The national society journals present selected research that has driven recent advances in clinical cardiology. Mater Sociomed (2011) 0.75
Ischemia-guided myocardial revascularization: the oculo-ischemic reflex. Arq Bras Cardiol (2014) 0.75
Almanac 2011: Heart Failure. The National Society Journals Present Selected Research that has Driven Recent Advances in Clinical Cardiology. Mater Sociomed (2011) 0.75
Chronic total occlusion: no more meta-analysis, please-a randomized clinical trial is urgently needed. J Thorac Dis (2015) 0.75
Gene Therapy in Cardiac Surgery: Clinical Trials, Challenges, and Perspectives. Ann Thorac Surg (2016) 0.75
Scar quantification by cardiovascular magnetic resonance as an independent predictor of long-term survival in patients with ischemic heart failure treated by coronary artery bypass graft surgery. J Cardiovasc Magn Reson (2016) 0.75
Facts and principles learned at the 39th Annual Williamsburg Conference on Heart Disease. Proc (Bayl Univ Med Cent) (2013) 0.75
To Revascularise or Not To Revascularise, That Is the Question: the Diagnostic and Management Conundrum of Ischaemic Cardiomyopathy. Curr Cardiol Rep (2016) 0.75
CABG in patients with left ventricular dysfunction. N Engl J Med (2011) 0.75
Heart failure in 2011: Heart failure therapy--technology to the fore. Nat Rev Cardiol (2012) 0.75
Assessment of stable coronary artery disease by cardiovascular magnetic resonance imaging: Current and emerging techniques. World J Cardiol (2017) 0.75
Association between High Endocardial Unipolar Voltage and Improved Left Ventricular Function in Patients with Ischemic Cardiomyopathy. Tex Heart Inst J (2016) 0.75
The role of coronary artery bypass grafting in patients with ischemic cardiomyopathy in the current era. J Thorac Dis (2016) 0.75
Severe ischemic cardiomyopathy-a new answer in management? Ann Transl Med (2016) 0.75
Coronary artery bypass grafting saves lives! J Thorac Dis (2016) 0.75
Heart failure in post-MI patients with persistent IRA occlusion: prevalence, risk factors, and the long-term effect of PCI in the Occluded Artery Trial (OAT). J Card Fail (2012) 0.75
Prediction of long-term segmental and global functional recovery of hibernating myocardium after revascularisation based on low dose dobutamine and late gadolinium enhancement cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2014) 0.75
Revascularization surgery as a treatment concept for heart failure. HSR Proc Intensive Care Cardiovasc Anesth (2013) 0.75
Effect of coronary artery bypass graft surgery on left ventricular systolic function. J Thorac Dis (2017) 0.75
CABG in patients with left ventricular dysfunction. N Engl J Med (2011) 0.75
Interventional therapies in ischemic ventricular dysfunction: facts and versions! Ann Transl Med (2016) 0.75
CABG in patients with left ventricular dysfunction. N Engl J Med (2011) 0.75
Coronary Artery Bypass Grafting in Patients with Advanced Left Ventricular Dysfunction: Excellent Early Outcome with Improved Ejection Fraction. J Tehran Heart Cent (2016) 0.75
Systolic heart failure: knowledge gaps, misconceptions, and future directions. Ochsner J (2014) 0.75
Integrated microRNA‑gene analysis of coronary artery disease based on miRNA and gene expression profiles. Mol Med Rep (2016) 0.75
Determinants of outcome in patients with chronic ischemic left ventricular dysfunction undergone percutaneous coronary interventions. BMC Cardiovasc Disord (2015) 0.75
Ischaemia change with revascularisation versus medical therapy in reduced ejection fraction. Open Heart (2015) 0.75
Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2009) 27.89
A multiple testing procedure for clinical trials. Biometrics (1979) 26.80
Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet (1994) 11.37
Covariance analysis of censored survival data. Biometrics (1974) 9.90
Guidelines on myocardial revascularization. Eur Heart J (2010) 8.85
Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med (2009) 7.71
Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med (2011) 6.65
Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation (1983) 3.99
Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. N Engl J Med (1988) 3.82
The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial. J Thorac Cardiovasc Surg (2007) 3.45
Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data. Circulation (1983) 3.17
F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J Am Coll Cardiol (2007) 2.50
A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction. N Engl J Med (1985) 2.49
STICH (Surgical Treatment for Ischemic Heart Failure) trial enrollment. J Am Coll Cardiol (2010) 2.39
Reversible ischemic left ventricular dysfunction: evidence for the "hibernating myocardium". J Am Coll Cardiol (1986) 2.20
Navigating the crossroads of coronary artery disease and heart failure. Circulation (2006) 2.06
Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. N Engl J Med (1984) 1.96
Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank). Am J Cardiol (2002) 1.60
The Heart Failure Revascularisation Trial (HEART). Eur J Heart Fail (2010) 1.57
Revascularization in severe left ventricular dysfunction: the role of viability testing. J Am Coll Cardiol (2005) 1.42
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med (2005) 27.36
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med (2002) 12.95
Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med (2011) 11.99
Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood. N Engl J Med (2004) 11.09
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med (2003) 10.57
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet (2009) 10.53
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. JAMA (2004) 9.74
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med (2004) 9.13
Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med (2006) 8.74
Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med (2015) 8.70
Third universal definition of myocardial infarction. Circulation (2012) 8.47
Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA (2002) 8.28
Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med (2012) 8.28
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation (2006) 8.01
Third universal definition of myocardial infarction. Eur Heart J (2012) 7.98
Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med (2009) 7.71
2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2014) 7.41
Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. N Engl J Med (2013) 7.35
Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation (2008) 7.11
Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med (2008) 6.77
Trial of Continuous or Interrupted Chest Compressions during CPR. N Engl J Med (2015) 6.66
Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med (2011) 6.65
Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med (2005) 6.53
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA (2009) 6.36
Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA (2005) 6.32
Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med (2008) 6.17
Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA (2005) 6.10
Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ (2014) 5.88
Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial. JAMA (2013) 5.31
Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA (2003) 5.30
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26
Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med (2008) 5.13
Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol (2008) 5.09
Effect of a clinical trial alert system on physician participation in trial recruitment. Arch Intern Med (2005) 5.08
Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial. JAMA (2013) 4.82
Home use of automated external defibrillators for sudden cardiac arrest. N Engl J Med (2008) 4.64
Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA (2007) 4.59
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Engl J Med (2012) 4.49
Human aortic valve calcification is associated with an osteoblast phenotype. Circulation (2003) 4.49
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2014) 4.34
Quality of life with defibrillator therapy or amiodarone in heart failure. N Engl J Med (2008) 4.33
Off-pump or on-pump coronary-artery bypass grafting at 30 days. N Engl J Med (2012) 4.32
Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA (2006) 4.30
Music, imagery, touch, and prayer as adjuncts to interventional cardiac care: the Monitoring and Actualisation of Noetic Trainings (MANTRA) II randomised study. Lancet (2005) 4.29
Effects of off-pump and on-pump coronary-artery bypass grafting at 1 year. N Engl J Med (2013) 4.27
Chronic diseases and injuries in India. Lancet (2011) 4.27
2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2014) 4.20
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation (2007) 4.16
Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol (2004) 4.14
Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation (2003) 3.97
A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol (2002) 3.97
Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol (2007) 3.92
Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation (2003) 3.92
Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail (2010) 3.90
Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II. Ann Intern Med (2005) 3.83
A trial of an impedance threshold device in out-of-hospital cardiac arrest. N Engl J Med (2011) 3.76
Impact of endoscopic versus open saphenous vein harvest techniques on outcomes after coronary artery bypass grafting. Ann Thorac Surg (2010) 3.71
Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA (2012) 3.66
2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg (2014) 3.59